Loading stock data…
Loading stock data…
US$2.80
Get one email when ADIL crosses your level. Checked every 15 minutes during market hours.
▲ +0.01 (0.36%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
55.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.10
Bearish momentumMACD below its signal line (0.13).
50-day average
2.36
Price aboveShort-term trend reference.
200-day average
4.49
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment and prevention of addiction and related disorders. Its lead investigational product, AD04, is a genetically targeted serotonin-3 receptor antagonist designed specifically for Alcohol Use Disorder in patients with certain genotypes, identified through the company's proprietary companion diagnostic genetic test. This precision medicine approach aims to address unmet needs i…
www.adial.com2 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-07-16 | 1.1 | 1.17 | ✓ Beat |
| 2026-06-25 | -0.14 | -0.16 | ✗ Miss |
| 2026-05-08 | -2.25 | -1.48 | ✓ Beat |
| 2026-03-05 | -2.13 | -11.48 | ✗ Miss |
| 2025-12-09 | 0.18 | 0.38 | ✓ Beat |
| 2025-11-13 | -3.5 | -2 | ✓ Beat |
| 2025-08-13 | -5.5 | -4.5 | ✓ Beat |
Companies in the same industry, via Finnhub